Global Azathioprine Market 2023-2030

    In Stock

    Coming Soon




    Azathioprine is an immunosuppressive drug that is marketed under the brand names Imuran and others. Rheumatoid arthritis, granulomatosis with polyangiitis, Crohn’s disease, ulcerative colitis, systemic lupus erythematosus, and kidney transplants to prevent rejection are among conditions it is used to treat.


    To stop the rejection of a transplanted kidney, azathioprine is utilised. It is a member of the class of drugs known as immunosuppressive agents. Azathioprine will reduce a patient’s natural immunity after transplantation in order to prevent rejection of the new kidney.


    Azathioprine is used to treat a variety of autoimmune illnesses, including rheumatoid arthritis, pemphigus, and pemphigus vulgaris, as well as to avoid rejection after organ transplantation. 




    infographic: Azathioprine Market , Azathioprine Market Size, Azathioprine Market Trends, Azathioprine Market Forecast, Azathioprine Market Risks, Azathioprine Market Report, Azathioprine Market Share


    The Global Azathioprine Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    An immunomodulator called azathioprine has a number of significant side effects. Age, genetic predispositions, and drug dosage all affect how toxic it is. The patient’s cooperation is limited by its negative side effects. As a result, frequent laboratory testing and routine follow-up are essential to preventing its consequences.


    Even in patients who are asymptomatic, clinicians and pharmacists should be aware of potential side effects of AZA. The remainder of the healthcare team should be informed of any disparities by pharmacists who have confirmed the dosage is suitable for the disease being treated.


    Azathioprine is a purine analogue that, through the actions of the enzymes hypoxanthine-guanine phosphoribosyltransferase (HPRT) and thiopurine methyltransferase (TPMT), transforms into its active metabolites, mercaptopurine (6-MP) and thioguanine (6-TGN).


    It then prevents the production of purines. Its metabolites stop division by integrating with the DNA that is duplicating. The majority of AZA’s toxic and immunosuppressive effects may also be mediated by its metabolites.


    AZA quickly passes through the digestive tract but does not cross the blood-brain barrier. Its liver-based metabolism and kidney-based excretion make it more hazardous in cases of renal failure.


    A drug called azathioprine (AZA) is used to control and treat active rheumatoid arthritis (RA), as well as to stop kidney transplant rejection. This activity discusses the benefits of azathioprine as a treatment for RA and other conditions when appropriate, as well as its actions and contraindications.


    The mechanism of action, adverse event profile, and other significant elements important for members of the interprofessional team in the treatment of patients with RA and related illnesses will be highlighted in this exercise. 





    1. How many Azathioprine are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Azathioprine and key vendor selection criteria
    3. Where is the Azathioprine manufactured? What is the average margin per unit?
    4. Market share of Global Azathioprine market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Azathioprine in-house
    6. key predictions for next 5 years in Global Azathioprine market
    7. Average B-2-B Azathioprine market price in all segments
    8. Latest trends in Azathioprine market, by every market segment
    9. The market size (both volume and value) of the Azathioprine market in 2023-2030 and every year in between?
    10. Production breakup of Azathioprine market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop